David Acosta
Impact in
- Biotechnology top 10%
- Microbial Inactivation Methods
- Parasitology top 10%
- Vector-borne infectious diseases
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
- Viral Infections and Vectors 1
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Philip Hanna (1 shared paper)R. John Collier (1 shared paper)Xin Li (2 shared papers)Tanja Petnicki‐Ocwieja (1 shared paper)Erin Chung (1 shared paper)Lester Kobzik (1 shared paper)Sanjukta Ghosh (1 shared paper)Ok Sarah Shin (1 shared paper)
- Journals
- Scientific Reports (1 paper)Cytokine (1 paper)PLoS Pathogens (1 paper)Frontiers in Microbiology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesEcuadorBrazil
In The Last Decade
David Acosta
9 papers receiving 329 citations
Peers
Comparison fields: 5 of 60
- Biotechnology 59
- Parasitology 42
- Virology 27
- Infectious Diseases 88
- Genetics 123
Countries citing papers authored by David Acosta
This map shows the geographic impact of David Acosta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Acosta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Acosta more than expected).
Fields of papers citing papers by David Acosta
This network shows the impact of papers produced by David Acosta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Acosta. The network helps show where David Acosta may publish in the future.
Co-authors
The 25 scholars most cited alongside David Acosta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 248 | |
| 2 | 2012 | 50 | |
| 3 | 2021 | 13 | |
| 4 | 2022 | 10 | |
| 5 | 2013 | 10 | |
| 6 | 2020 | 4 | |
| 7 | 2023 | 4 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 1 |
About David Acosta
David Acosta is a scholar working on Infectious Diseases, Neurology, Epidemiology, Organic Chemistry and Surgery, having authored 9 papers that have together received 342 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers), Adolescent and Pediatric Healthcare (1 paper), Bacterial Genetics and Biotechnology (1 paper), Vector-borne infectious diseases (1 paper) and Viral Infections and Vectors (1 paper). The work is most often cited by research in Biotechnology (59 citations), Parasitology (42 citations), Virology (27 citations), Infectious Diseases (88 citations) and Genetics (123 citations). David Acosta has collaborated with scholars based in United States, Ecuador and Brazil. Frequent co-authors include Philip Hanna, R. John Collier, Xin Li, Tanja Petnicki‐Ocwieja, Erin Chung, Lester Kobzik, Sanjukta Ghosh, Ok Sarah Shin, Linden T. Hu and Alain Debrabant. Their work appears in journals such as Scientific Reports, Cytokine, PLoS Pathogens, Frontiers in Microbiology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.